The decrease in the genus Akkermansia is noteworthy, since Akkermansia muciniphila is often considered a beneficial bacterium in humans and a decrease in its abundance has been associated with adverse metabolic outcomes in the context of obesity, including increased adiposity, impaired gut barrier function, and insulin resistance. The gene discussed is INS; the disease is obesity disorder.